Valacyclovir Shows Promise in Treating Herpes Zoster Ophthalmicus, Study Finds

Recent research presented at the American Academy of Ophthalmology highlights the benefits of valacyclovir in treating herpes zoster ophthalmicus (HZO). Led by Dr. Elisabeth Cohen, the study found that valacyclovir significantly reduces the risk of new or worsening eye disease and decreases the need for neuropathic pain medications. These findings support the use of valacyclovir as a key treatment option for improving the quality of life in HZO patients.